Minimal Residual Disease Status as a Surrogate Endpoint for Progression-free Survival in Newly Diagnosed Multiple Myeloma Studies: A Meta-analysis

  1. Avet-Loiseau, H.
  2. Ludwig, H.
  3. Landgren, O.
  4. Paiva, B.
  5. Morris, C.
  6. Yang, H.
  7. Zhou, K.
  8. Ro, S.
  9. Mateos, M.-V.
Revue:
Clinical Lymphoma, Myeloma and Leukemia

ISSN: 2152-2669,  2152-2650

Année de publication: 2020

Volumen: 20

Número: 1

Pages: e30-e37

Type: Article

DOI: 10.1016/J.CLML.2019.09.622 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus